GlaxoSmithKline plc (GSKN) — Long-term Investment Intensity
GlaxoSmithKline plc (GSKN) has a Long-term Investment Intensity of 2.7% as of December 2019. Long-term investments of MX$2.16 Billion represent 2.7% of total assets of MX$79.69 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of GlaxoSmithKline plc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GlaxoSmithKline plc Long-term Investment Intensity (2013–2019)
This chart shows how GlaxoSmithKline plc's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 2.7%, reflecting long-term investments of MX$2.16 Billion against total assets of MX$79.69 Billion MXN. Explore debt repayment capacity of GlaxoSmithKline plc to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for GlaxoSmithKline plc (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for GlaxoSmithKline plc from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see GSKN market cap.
| Year | LT Investment Intensity | LT Investments (MXN) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.7% | MX$2.16 Billion | MX$79.69 Billion | ▲ +0.0 pp |
| 2018 | 2.7% | MX$1.56 Billion | MX$58.07 Billion | ▲ +0.7 pp |
| 2017 | 2.0% | MX$1.11 Billion | MX$56.38 Billion | ▼ -0.1 pp |
| 2016 | 2.1% | MX$1.25 Billion | MX$59.08 Billion | ▼ -0.6 pp |
| 2015 | 2.7% | MX$1.46 Billion | MX$53.45 Billion | ▼ -0.8 pp |
| 2014 | 3.6% | MX$1.45 Billion | MX$40.65 Billion | ▼ 0.0 pp |
| 2013 | 3.6% | MX$1.53 Billion | MX$42.09 Billion | — |